Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
ALK-Abelló (Germany) · Alnylam Pharmaceuticals (United States)
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,176
total citations
- FWCI
- 56.65
- Percentile
- 100%
- References
- 22
Citations per year
Authors
25Topics & keywords
Topics
Keywords
- Small interfering RNA
- Gene silencing
- RNA interference
- RNA silencing
- Systemic administration
- Apolipoprotein B
- Biology
- Cell biology
No related works found for this paper.